Loading…

The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles

BACKGROUND: Withholding gonadotrophin administration and postponing HCG injection, termed coasting, has been suggested as a treatment modality in cases of impending ovarian hyperstimulation syndrome (OHSS). It presents an opportunity to reduce the risk of OHSS and salvage the treatment, without appa...

Full description

Saved in:
Bibliographic Details
Published in:Human reproduction (Oxford) 2002-02, Vol.17 (2), p.310-313
Main Authors: Ulug, Ulun, Bahceci, Mustafa, Erden, Halit F., Shalev, Eliezer, Ben-Shlomo, Izhar
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c437t-6e0252475aaefa7d72dd6724efa6b21ff38bdf1836cc6fca041fe401133fbedc3
cites
container_end_page 313
container_issue 2
container_start_page 310
container_title Human reproduction (Oxford)
container_volume 17
creator Ulug, Ulun
Bahceci, Mustafa
Erden, Halit F.
Shalev, Eliezer
Ben-Shlomo, Izhar
description BACKGROUND: Withholding gonadotrophin administration and postponing HCG injection, termed coasting, has been suggested as a treatment modality in cases of impending ovarian hyperstimulation syndrome (OHSS). It presents an opportunity to reduce the risk of OHSS and salvage the treatment, without apparent compromise to outcome. However, the duration of the coasting period, which would maintain the advantage without reducing conception rate, has not been fully established. In this retrospective study, we attempted to define the optimal interval of coasting in patients at risk of developing OHSS. METHODS: Patients were grouped according to the number of days elapsed between cessation of gonadotrophins and administration of HCG. Overall, out of 207 patients (mean age 30.76 ± 0.33 years) coasting lasted 1 day in 39 cycles (18.8%), 2 days in 61 cycles (29.4%), 3 days in 49 cycles (23.6%) and │4 days in the remaining 58 cycles (28.5%). RESULTS: There was no difference between the groups in patients' age, serum estradiol concentrations at the time of HCG administration, oocyte maturity, fertilization and embryo cleavage rates. However, patients in whom coasting lasted │4 days had significantly reduced implantation (10.5%) and pregnancy (26.7%) rates compared with patients with a shorter coasting interval (ranges 18.4–27.9 and 41–55.7% respectively; P < 0.05). CONCLUSION: Coasting for >3 days appears to reduce implantation and pregnancy rates while in-vitro oocyte and embryo quality do not appear to be affected. We suggest that in patients who need coasting for >3 days, cryopreservation of embryos should be considered.
doi_str_mv 10.1093/humrep/17.2.310
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71427253</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/humrep/17.2.310</oup_id><sourcerecordid>71427253</sourcerecordid><originalsourceid>FETCH-LOGICAL-c437t-6e0252475aaefa7d72dd6724efa6b21ff38bdf1836cc6fca041fe401133fbedc3</originalsourceid><addsrcrecordid>eNqNkE1LxDAQhoMouq6evUkvehC6m0napHsUv3FBDwriJWTTRKNtU5NW1F9v1i569ZLMyzwzAw9Ce4AngGd0-tzXXrdT4BMyoYDX0AgyhlNCc7yORpiwIgVgsIW2Q3jBOJYF20RbAAUBwmYj1N496yTYp8Yaq2SjdOJMopwMnW2ekrL3srOuWRbL7N6lt7JJYrfuq6FlnI8DcbL9ibZJZAg2dLpMjPadrezXAKpPVemwgzaMrILeXf1jdH9-dndymc5vLq5OjuepyijvUqYxyUnGcym1kbzkpCwZJ1kMbEHAGFosSgMFZUoxoyTOwOgMA1BqFrpUdIwOh72td2-9Dp2obVC6qmSjXR8Eh4xwktMITgdQeReC10a03tbSfwrAYilZDJIFcEFElBwn9ler-0Wtyz9-ZTUCBytABiUr46NYG_44mtOsiM8YHQ2c69t_XE0HeOn24xeX_lUwTnkuLh8exTXMTm-LRy7m9Bu686cR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71427253</pqid></control><display><type>article</type><title>The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles</title><source>Oxford Journals Online</source><creator>Ulug, Ulun ; Bahceci, Mustafa ; Erden, Halit F. ; Shalev, Eliezer ; Ben-Shlomo, Izhar</creator><creatorcontrib>Ulug, Ulun ; Bahceci, Mustafa ; Erden, Halit F. ; Shalev, Eliezer ; Ben-Shlomo, Izhar</creatorcontrib><description>BACKGROUND: Withholding gonadotrophin administration and postponing HCG injection, termed coasting, has been suggested as a treatment modality in cases of impending ovarian hyperstimulation syndrome (OHSS). It presents an opportunity to reduce the risk of OHSS and salvage the treatment, without apparent compromise to outcome. However, the duration of the coasting period, which would maintain the advantage without reducing conception rate, has not been fully established. In this retrospective study, we attempted to define the optimal interval of coasting in patients at risk of developing OHSS. METHODS: Patients were grouped according to the number of days elapsed between cessation of gonadotrophins and administration of HCG. Overall, out of 207 patients (mean age 30.76 ± 0.33 years) coasting lasted 1 day in 39 cycles (18.8%), 2 days in 61 cycles (29.4%), 3 days in 49 cycles (23.6%) and │4 days in the remaining 58 cycles (28.5%). RESULTS: There was no difference between the groups in patients' age, serum estradiol concentrations at the time of HCG administration, oocyte maturity, fertilization and embryo cleavage rates. However, patients in whom coasting lasted │4 days had significantly reduced implantation (10.5%) and pregnancy (26.7%) rates compared with patients with a shorter coasting interval (ranges 18.4–27.9 and 41–55.7% respectively; P &lt; 0.05). CONCLUSION: Coasting for &gt;3 days appears to reduce implantation and pregnancy rates while in-vitro oocyte and embryo quality do not appear to be affected. We suggest that in patients who need coasting for &gt;3 days, cryopreservation of embryos should be considered.</description><identifier>ISSN: 0268-1161</identifier><identifier>ISSN: 1460-2350</identifier><identifier>EISSN: 1460-2350</identifier><identifier>DOI: 10.1093/humrep/17.2.310</identifier><identifier>PMID: 11821269</identifier><identifier>CODEN: HUREEE</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Biological and medical sciences ; Birth control ; Chorionic Gonadotropin - administration &amp; dosage ; coasting ; Drug Administration Schedule ; Embryo Implantation ; Female ; Gonadotropins - administration &amp; dosage ; Gynecology. Andrology. Obstetrics ; Humans ; implantation rate ; Medical sciences ; Ovarian Hyperstimulation Syndrome - prevention &amp; control ; ovarian stimulation ; Pregnancy ; Pregnancy Rate ; Reproductive Techniques ; Retrospective Studies ; Sterility. Assisted procreation</subject><ispartof>Human reproduction (Oxford), 2002-02, Vol.17 (2), p.310-313</ispartof><rights>European Society of Human Reproduction and Embryology 2002</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c437t-6e0252475aaefa7d72dd6724efa6b21ff38bdf1836cc6fca041fe401133fbedc3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13534835$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11821269$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ulug, Ulun</creatorcontrib><creatorcontrib>Bahceci, Mustafa</creatorcontrib><creatorcontrib>Erden, Halit F.</creatorcontrib><creatorcontrib>Shalev, Eliezer</creatorcontrib><creatorcontrib>Ben-Shlomo, Izhar</creatorcontrib><title>The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles</title><title>Human reproduction (Oxford)</title><addtitle>Hum. Reprod</addtitle><addtitle>Hum. Reprod</addtitle><description>BACKGROUND: Withholding gonadotrophin administration and postponing HCG injection, termed coasting, has been suggested as a treatment modality in cases of impending ovarian hyperstimulation syndrome (OHSS). It presents an opportunity to reduce the risk of OHSS and salvage the treatment, without apparent compromise to outcome. However, the duration of the coasting period, which would maintain the advantage without reducing conception rate, has not been fully established. In this retrospective study, we attempted to define the optimal interval of coasting in patients at risk of developing OHSS. METHODS: Patients were grouped according to the number of days elapsed between cessation of gonadotrophins and administration of HCG. Overall, out of 207 patients (mean age 30.76 ± 0.33 years) coasting lasted 1 day in 39 cycles (18.8%), 2 days in 61 cycles (29.4%), 3 days in 49 cycles (23.6%) and │4 days in the remaining 58 cycles (28.5%). RESULTS: There was no difference between the groups in patients' age, serum estradiol concentrations at the time of HCG administration, oocyte maturity, fertilization and embryo cleavage rates. However, patients in whom coasting lasted │4 days had significantly reduced implantation (10.5%) and pregnancy (26.7%) rates compared with patients with a shorter coasting interval (ranges 18.4–27.9 and 41–55.7% respectively; P &lt; 0.05). CONCLUSION: Coasting for &gt;3 days appears to reduce implantation and pregnancy rates while in-vitro oocyte and embryo quality do not appear to be affected. We suggest that in patients who need coasting for &gt;3 days, cryopreservation of embryos should be considered.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Birth control</subject><subject>Chorionic Gonadotropin - administration &amp; dosage</subject><subject>coasting</subject><subject>Drug Administration Schedule</subject><subject>Embryo Implantation</subject><subject>Female</subject><subject>Gonadotropins - administration &amp; dosage</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>implantation rate</subject><subject>Medical sciences</subject><subject>Ovarian Hyperstimulation Syndrome - prevention &amp; control</subject><subject>ovarian stimulation</subject><subject>Pregnancy</subject><subject>Pregnancy Rate</subject><subject>Reproductive Techniques</subject><subject>Retrospective Studies</subject><subject>Sterility. Assisted procreation</subject><issn>0268-1161</issn><issn>1460-2350</issn><issn>1460-2350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqNkE1LxDAQhoMouq6evUkvehC6m0napHsUv3FBDwriJWTTRKNtU5NW1F9v1i569ZLMyzwzAw9Ce4AngGd0-tzXXrdT4BMyoYDX0AgyhlNCc7yORpiwIgVgsIW2Q3jBOJYF20RbAAUBwmYj1N496yTYp8Yaq2SjdOJMopwMnW2ekrL3srOuWRbL7N6lt7JJYrfuq6FlnI8DcbL9ibZJZAg2dLpMjPadrezXAKpPVemwgzaMrILeXf1jdH9-dndymc5vLq5OjuepyijvUqYxyUnGcym1kbzkpCwZJ1kMbEHAGFosSgMFZUoxoyTOwOgMA1BqFrpUdIwOh72td2-9Dp2obVC6qmSjXR8Eh4xwktMITgdQeReC10a03tbSfwrAYilZDJIFcEFElBwn9ler-0Wtyz9-ZTUCBytABiUr46NYG_44mtOsiM8YHQ2c69t_XE0HeOn24xeX_lUwTnkuLh8exTXMTm-LRy7m9Bu686cR</recordid><startdate>20020201</startdate><enddate>20020201</enddate><creator>Ulug, Ulun</creator><creator>Bahceci, Mustafa</creator><creator>Erden, Halit F.</creator><creator>Shalev, Eliezer</creator><creator>Ben-Shlomo, Izhar</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020201</creationdate><title>The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles</title><author>Ulug, Ulun ; Bahceci, Mustafa ; Erden, Halit F. ; Shalev, Eliezer ; Ben-Shlomo, Izhar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c437t-6e0252475aaefa7d72dd6724efa6b21ff38bdf1836cc6fca041fe401133fbedc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Birth control</topic><topic>Chorionic Gonadotropin - administration &amp; dosage</topic><topic>coasting</topic><topic>Drug Administration Schedule</topic><topic>Embryo Implantation</topic><topic>Female</topic><topic>Gonadotropins - administration &amp; dosage</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>implantation rate</topic><topic>Medical sciences</topic><topic>Ovarian Hyperstimulation Syndrome - prevention &amp; control</topic><topic>ovarian stimulation</topic><topic>Pregnancy</topic><topic>Pregnancy Rate</topic><topic>Reproductive Techniques</topic><topic>Retrospective Studies</topic><topic>Sterility. Assisted procreation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ulug, Ulun</creatorcontrib><creatorcontrib>Bahceci, Mustafa</creatorcontrib><creatorcontrib>Erden, Halit F.</creatorcontrib><creatorcontrib>Shalev, Eliezer</creatorcontrib><creatorcontrib>Ben-Shlomo, Izhar</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human reproduction (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ulug, Ulun</au><au>Bahceci, Mustafa</au><au>Erden, Halit F.</au><au>Shalev, Eliezer</au><au>Ben-Shlomo, Izhar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles</atitle><jtitle>Human reproduction (Oxford)</jtitle><stitle>Hum. Reprod</stitle><addtitle>Hum. Reprod</addtitle><date>2002-02-01</date><risdate>2002</risdate><volume>17</volume><issue>2</issue><spage>310</spage><epage>313</epage><pages>310-313</pages><issn>0268-1161</issn><issn>1460-2350</issn><eissn>1460-2350</eissn><coden>HUREEE</coden><abstract>BACKGROUND: Withholding gonadotrophin administration and postponing HCG injection, termed coasting, has been suggested as a treatment modality in cases of impending ovarian hyperstimulation syndrome (OHSS). It presents an opportunity to reduce the risk of OHSS and salvage the treatment, without apparent compromise to outcome. However, the duration of the coasting period, which would maintain the advantage without reducing conception rate, has not been fully established. In this retrospective study, we attempted to define the optimal interval of coasting in patients at risk of developing OHSS. METHODS: Patients were grouped according to the number of days elapsed between cessation of gonadotrophins and administration of HCG. Overall, out of 207 patients (mean age 30.76 ± 0.33 years) coasting lasted 1 day in 39 cycles (18.8%), 2 days in 61 cycles (29.4%), 3 days in 49 cycles (23.6%) and │4 days in the remaining 58 cycles (28.5%). RESULTS: There was no difference between the groups in patients' age, serum estradiol concentrations at the time of HCG administration, oocyte maturity, fertilization and embryo cleavage rates. However, patients in whom coasting lasted │4 days had significantly reduced implantation (10.5%) and pregnancy (26.7%) rates compared with patients with a shorter coasting interval (ranges 18.4–27.9 and 41–55.7% respectively; P &lt; 0.05). CONCLUSION: Coasting for &gt;3 days appears to reduce implantation and pregnancy rates while in-vitro oocyte and embryo quality do not appear to be affected. We suggest that in patients who need coasting for &gt;3 days, cryopreservation of embryos should be considered.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>11821269</pmid><doi>10.1093/humrep/17.2.310</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0268-1161
ispartof Human reproduction (Oxford), 2002-02, Vol.17 (2), p.310-313
issn 0268-1161
1460-2350
1460-2350
language eng
recordid cdi_proquest_miscellaneous_71427253
source Oxford Journals Online
subjects Adult
Biological and medical sciences
Birth control
Chorionic Gonadotropin - administration & dosage
coasting
Drug Administration Schedule
Embryo Implantation
Female
Gonadotropins - administration & dosage
Gynecology. Andrology. Obstetrics
Humans
implantation rate
Medical sciences
Ovarian Hyperstimulation Syndrome - prevention & control
ovarian stimulation
Pregnancy
Pregnancy Rate
Reproductive Techniques
Retrospective Studies
Sterility. Assisted procreation
title The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T19%3A18%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20significance%20of%20coasting%20duration%20during%20ovarian%20stimulation%20for%20conception%20in%20assisted%20fertilization%20cycles&rft.jtitle=Human%20reproduction%20(Oxford)&rft.au=Ulug,%20Ulun&rft.date=2002-02-01&rft.volume=17&rft.issue=2&rft.spage=310&rft.epage=313&rft.pages=310-313&rft.issn=0268-1161&rft.eissn=1460-2350&rft.coden=HUREEE&rft_id=info:doi/10.1093/humrep/17.2.310&rft_dat=%3Cproquest_cross%3E71427253%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c437t-6e0252475aaefa7d72dd6724efa6b21ff38bdf1836cc6fca041fe401133fbedc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71427253&rft_id=info:pmid/11821269&rft_oup_id=10.1093/humrep/17.2.310&rfr_iscdi=true